XBIOTECH INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
XBIOTECH INC. (XBIT) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $0.00 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2026-08-13
- XBIOTECH INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2026-03-31 was $0.00.
- XBIOTECH INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- XBIOTECH INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2024-03-31 was $3.96.
- XBIOTECH INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2018-03-31 was $2.50.
- XBIOTECH INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2025 was $0.00.
- XBIOTECH INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $3.84.
- XBIOTECH INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2018 was $2.50.
- XBIOTECH INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2015 was $3.75, a 62.50% decline from fiscal 2014.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 1 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-13 | ||||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 | ||||
| 2025-12-31 | $0.00 10-K · filed 2026-03-13 | ||||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-13 | ||||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-14 | ||||
| 2024-09-30 | $3.92 10-Q · filed 2025-11-12 | ||||
| 2024-06-30 | $3.92 10-Q · filed 2025-08-13 | ||||
| 2024-03-31 | $3.96 10-Q · filed 2025-05-14 | ||||
| 2023-12-31 | $3.84 10-K · filed 2025-03-18 | ||||
| 2023-09-30 | $3.84 10-Q · filed 2024-11-13 | ||||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-09 | ||||
| 2018-12-31 | $2.50 10-K · filed 2020-03-16 | ||||
| 2018-09-30 | $2.50 10-Q · filed 2018-10-31 | ||||
| 2018-06-30 | $2.50 10-Q · filed 2018-08-09 | ||||
| 2018-03-31 | $2.50 10-Q · filed 2018-10-31 | ||||
| 2017-09-30 | $2.50 10-Q · filed 2017-11-09 | ||||
| 2016-09-30 | $10.51 10-Q · filed 2016-11-14 | ||||
| 2016-06-30 | $4.96 10-Q · filed 2016-11-14 | ||||
| 2016-03-31 | $2.50 10-Q · filed 2016-11-14 | ||||
| 2016-01-28 | $2.50 10-Q · filed 2016-08-12 | ||||
| 2015-12-31 | $3.75 10-K · filed 2016-04-15 | ||||
| 2015-09-30 | $2.50 10-Q · filed 2015-11-13 | ||||
| 2015-07-31 | $2.50 10-K · filed 2017-03-16 | ||||
| 2015-06-30 | $6.32 10-Q · filed 2015-11-13 | ||||
| 2015-03-31 | $0.56 10-Q · filed 2015-11-13 | ||||
| 2015-01-31 | $0.55 10-K · filed 2017-03-16 | ||||
| 2014-12-31 | $10.00 10-K · filed 2017-03-16 | $10.00 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |